Mapping HIV reservoir establishment in human tonsil organoids
Active Project Grant Awarded Last action
- Award ID
- F31AI200607
- Recipient
-
Icahn School Of Medicine At Mount Sinai UEI C8H9CNG1VBD9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $100,228
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 0% complete
- Originally
- Place of performance
- New York, NY 10029, USA
Award details come from USAspending.gov.
About this award
The National Institute of Allergy and Infectious Diseases awarded Icahn School of Medicine at Mount Sinai $100,228 on November 15, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to map HIV reservoir establishment in human tonsil organoids.
The research will characterize nonproductively infected cells—those harboring integrated HIV proviruses that express no viral proteins and thus evade clearance by antiviral treatments and the immune system—as a barrier to HIV cure. The work leverages a dual-reporter virus system to physically separate nonproductively infected cells from productively infected and uninfected cells, and employs human tonsil lymphoid organoids to model tissue-level infection dynamics. Specific Aim 1 applies spectral flow cytometry to phenotype cell types in the tonsil organoid model, identifying those harboring nonproductive proviruses and comparing results to blood-derived CD4+ T cells while measuring bystander cell impact on the ratio of productive to nonproductive infections; RNA sequencing will compare transcriptomic landscapes across infection states. Specific Aim 2 identifies viral characteristics correlating with nonproductive infection using digital PCR and other established and novel techniques.
Performance occurs in New York, New York with a period extending through May 31, 2029. The assistance type is a Project Grant.
Description
- Abstract
- Combination antiretroviral treatment has transformed HIV (human immunodeficiency virus) infection from a fatal disease to a manageable chronic condition. IT requires, however, regular antiretroviral medication. Attempts to cure HIV fall short because of the existence of long-lived HIV reservoirs comprised of cells harboring non- productive proviruses. While HIV is integrated into the genome of these cells, no viral proteins are expressed, leaving the cells indistinguishable from uninfected cells, preventing clearance by antiviral treatments or the immune system. My proposal seeks to define the properties and features of nonproductively infected cells circulating in the blood or residing in lymphoid tissues. My project will leverage a dual-reporter virus which allows for the physical separation of cells nonproductively infected with HIV from those that are productively infected and uninfected cells. Additionally, we have worked to develop methods of culturing and infecting lymphoid cells derived from human tonsils to mimic infection in tissues. Utilizing these model systems, we will work to understand cellular and viral factors which influence nonproductive HIV infection. In specific aim 1, i will utilize spectral flow cytometry to phenotype the cell types present in our tonsil organoid model, delineating the cells that harbor non-productive proviruses. We will compare these results to those found in blood derived CD4+ t cells and measure the impact of other bystander cell types on the relative frequency of productive to non-productive infections. We will use RNA sequencing to compare the transcriptomic landscapes of nonproductively infected cells to those of productively infected cells. In specific aim 2, we will utilize established and novel techniques to identify viral characteristics which correlate with nonproductive HIV infection. We will use digital PCR technologies to measure proviral intactness, and parallel sequencing techniques to identify HIV integration sites. These experiments will collectively identify host and viral factors which play a role in HIV latency establishment in relevant primary human cells and organoid model systems. This research will be supervised by DR. Viviana simon, a recognized leader in the field of virology. I will additionally be aided by esteemed collaborators both at our institution and beyond, who will assist with technical aspects as well as my development as a budding researcher. My fellowship proposal will generate new insights into the non-productive HIV reservoir, provide opportunities to learn advanced techniques both on the bench and in data analysis, and prepare me for a successful career as an independent academic researcher and mentor.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $50,114 | |
| Amendment | $50,114 | |
| Original award | $0 |
Quick answers
Who received award F31AI200607?
F31AI200607 was awarded to Icahn School Of Medicine At Mount Sinai by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 15, 2026.
How much is award F31AI200607 worth?
$100,228 has been obligated on F31AI200607.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award